Methods of Telomerase Inhibition
Open Access
- 1 January 2007
- book chapter
- research article
- Published by Springer Science and Business Media LLC
- Vol. 405, 1-8
- https://doi.org/10.1007/978-1-60327-070-0_1
Abstract
Telomerase is central to cellular immortality and is a key component of most cancer cells although this enzyme is rarely expressed to significant levels in normal cells. Therefore, the inhibition of telomerase has garnered considerable attention as a possible anticancer approach. Many of the methods applied to telomerase inhibition focus on either of the two major components of the ribonucleoprotein holoenzyme, that is, the telomerase reverse transcriptase (TERT) catalytic subunit or the telomerase RNA (TR) component. Other protocols have been developed to target the proteins, such as tankyrase, that are associated with telomerase at the ends of chromosomes. This chapter summarizes some of these recent advances in telomerase inhibition.Keywords
This publication has 8 references indexed in Scilit:
- Analysis of telomerase activity and detection of its catalytic subunit, hTERTAnalytical Biochemistry, 2003
- Telomeres, Telomerase, and Telomerase Inhibition: Clinical Implications for CancerJournal of the American Geriatrics Society, 2003
- Telomeres and Telomerase: Basic Science Implications for AgingJournal of the American Geriatrics Society, 2001
- Molecular targeting of cancer: Telomeres as targetsProceedings of the National Academy of Sciences of the United States of America, 2001
- Reconstitution of human telomerase activity in vitroCurrent Biology, 1998
- Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRTNature Genetics, 1997
- Regulation mechanisms of mammalian telomerase. A review.1997
- A survey of telomerase activity in human cancerEuropean Journal Of Cancer, 1997